Search details
1.
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
N Engl J Med
; 387(8): 692-703, 2022 08 25.
Article
in English
| MEDLINE | ID: mdl-35833805
2.
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40.
Ophthalmology
; 2024 Feb 08.
Article
in English
| MEDLINE | ID: mdl-38336282
3.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Lancet
; 399(10326): 741-755, 2022 02 19.
Article
in English
| MEDLINE | ID: mdl-35085503
4.
Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to Electronic ETDRS Protocol Visual Acuity Assessment.
Ophthalmology
; 130(5): 533-541, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36521571
5.
Computational investigation of blood cell transport in retinal microaneurysms.
PLoS Comput Biol
; 18(1): e1009728, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34986147
6.
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA.
Retina
; 43(4): 616-623, 2023 04 01.
Article
in English
| MEDLINE | ID: mdl-36728692
7.
INTEGRATING MACULAR OPTICAL COHERENCE TOMOGRAPHY WITH ULTRAWIDE-FIELD IMAGING IN A DIABETIC RETINOPATHY TELEMEDICINE PROGRAM USING A SINGLE DEVICE.
Retina
; 43(11): 1928-1935, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37871272
8.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
JAMA
; 329(5): 376-385, 2023 02 07.
Article
in English
| MEDLINE | ID: mdl-36749332
9.
ASSESSMENT OF FLUORESCEIN ANGIOGRAPHY NONPERFUSION IN EYES WITH DIABETIC RETINOPATHY USING ULTRAWIDE FIELD RETINAL IMAGING.
Retina
; 42(7): 1302-1310, 2022 07 01.
Article
in English
| MEDLINE | ID: mdl-35344528
10.
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH.
Ophthalmology
; 128(11): 1592-1603, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33989683
11.
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).
Ophthalmology
; 127(9): 1201-1210, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32402554
12.
Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trial.
Clin Trials
; 17(2): 195-201, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31984762
13.
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical Trials.
Retina
; 40(6): 1021-1028, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-31567817
14.
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
JAMA
; 324(23): 2383-2395, 2020 12 15.
Article
in English
| MEDLINE | ID: mdl-33320223
15.
Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab: Open-Label Extension of RIDE and RISE Studies.
Ophthalmology
; 126(5): 712-720, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30419298
16.
Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy.
Ophthalmology
; 126(1): 87-95, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30096354
17.
The Diabetic Retinopathy Clinical Research Network (DRCR.net) and Its Contributions to the Treatment of Diabetic Retinopathy.
Ophthalmic Res
; 62(4): 225-230, 2019.
Article
in English
| MEDLINE | ID: mdl-31554001
18.
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
JAMA
; 321(19): 1880-1894, 2019 05 21.
Article
in English
| MEDLINE | ID: mdl-31037289
19.
Evaluation and Care of Patients with Diabetic Retinopathy. Reply.
N Engl J Med
; 383(5): e31, 2020 07 30.
Article
in English
| MEDLINE | ID: mdl-32726546
20.
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
N Engl J Med
; 372(13): 1193-203, 2015 Mar 26.
Article
in English
| MEDLINE | ID: mdl-25692915